Despite governmental assurances regarding Kenya's readiness to combat a potential Ebola outbreak, health experts are voicing serious concerns about the country's isolation and treatment infrastructure. They highlight significant gaps in training protocols, laboratory capabilities, and crucial infection control systems, warning that current provisions remain largely inadequate. This critical assessment comes as the Ministry of Health proceeds with the establishment of 23 proposed Ebola isolation and treatment facilities nationwide, including in Laikipia County, as part of its comprehensive national preparedness and response framework.

The regional effort to contain the hemorrhagic fever has received a significant boost from the German Development Bank (KfW), which has committed an emergency financial injection of Ksh150 million (€1 million). This funding is specifically earmarked to bolster East Africa’s border surveillance and diagnostic infrastructure, with Kenya designated as a primary beneficiary. The East African Community (EAC) Secretariat confirmed that these funds would be immediately utilized to accelerate the activation of mobile laboratories, procure essential diagnostic reagents, and provide specialized training for technical laboratory personnel across the regional bloc. This agreement was solidified during the 8th Extraordinary Meeting of EAC Ministers of Health, a virtual summit convened to forge a unified containment strategy amidst rising cross-border transmission risks.

The urgency of these measures is underscored by concerning health statistics indicating the pathogen's spread along regional trade and transit corridors. The Democratic Republic of Congo (DRC) remains the epicenter, reporting 121 confirmed cases and 1,077 suspected cases, with 246 deaths among suspected patients. Neighboring Uganda is on high alert after confirming 11 cases and one official fatality, intensifying fears of wider regional transmission. To counter this, ten German-funded mobile laboratories are already operational across Kenya, Uganda, the DRC, Rwanda, Burundi, South Sudan, and Tanzania, receiving continuous technical support from the Bernhard Nocht Institute for Tropical Medicine. EAC Ministers have further mandated the Secretariat to expedite the procurement and deployment of additional containerized laboratories to address diagnostic deficiencies throughout the region.

In response to the escalating regional alert, President William Ruto affirmed that Kenya has operationalized 23 specialized Ebola preparedness and isolation centers. These strategically distributed facilities are located across key transit counties, including major urban hubs like Kenyatta National Hospital (KNH) branches in Nairobi and Thika, transit corridors such as Moi Teaching and Referral Hospital (MTRH) in Eldoret, and border gateways like Alupe Sub-County Hospital in Busia. While these centers are designed for physical screening, quarantine, and initial patient management, actual blood work and diagnostic verification are rigorously conducted by secure Biosafety Level 3 laboratories managed by the Kenya Medical Research Institute (KEMRI) and the National Public Health Laboratory.

However, the regional support package has ignited an internal political and public debate, particularly concerning a proposed 50-bed, U.S.-backed isolation unit at the Laikipia Air Base. This facility is designated to host American medical personnel exposed to Ebola. Despite an active High Court injunction and significant public resistance in Nanyuki, President Ruto has staunchly defended the international partnership, asserting its integral role within Kenya’s broader pandemic preparedness framework and emphasizing the critical importance of international medical alliances in managing highly contagious regional health threats.

Health Cabinet Secretary Aden Duale has remained firm, vowing to proceed with the Laikipia facility despite public opposition and the court order. Duale insisted before Parliament that the facility would be accessible to all, a claim that seemingly contradicted statements from the American government, which had indicated the unit was primarily for its citizens in the DRC. The government, through Duale and Medical Services Principal Secretary Ouma Oluga, later acknowledged shortcomings in communicating the details of the Kenya-US agreement to the public, pledging to improve their communication strategy. PS Oluga clarified that the decision to build the facility in Kenya, rather than the DRC, was influenced by past attacks on isolation centers in the DRC and existing bilateral health agreements with the United States. Duale, defending President Ruto's decision and the Sh1.7 billion U.S. funding, argued that the Public Health Act guided the project, making public consultation unnecessary during an epidemic. He stressed the government's responsibility to protect both Kenyans and non-Kenyans within its borders, maintaining that the facility remains under Kenyan control and does not compromise national sovereignty. He also noted that it is part of a broader regional effort involving over 20 similar facilities in high-risk areas. Additionally, Duale informed lawmakers that 71,243 people had been screened at Kenya's borders, with 256 screenings occurring in a single 24-hour period. Oluga also pointed out that Kenya currently lacks private facilities capable of conducting Ebola tests, relying solely on government laboratories like KEMRI, which are also engaged in vaccine-related tests for the current strain.